Dan Finke is Executive Vice President, CVS Health and President of the Health Care Benefits (HCB) Segment. He is responsible for driving the CVS Health strategy to deliver consumer-focused, high value health care to the more than 34 million members served by HCB. He is also charged with simplifying the health experience for members using digital solutions, making health care more affordable and bringing to market CVS Health’s combined capabilities that demonstrate the company’s unique ability to serve the needs of customers, members and providers. He is a member of the CVS Health executive team.
Dan is passionate about addressing mental health stigma. He is also deeply committed to attain health equity for all Americans, by engaging public and private stakeholders to address social determinants of health through analytics-based approaches that offer new insight and opportunities into health care disparities.
Dan has more than 25 years of diverse health care leadership experience. He joined Aetna in 2014 and most recently led the Commercial Business and Markets organization, responsible for the multi-billion-dollar organization that delivers transformational, customer-focused benefits solutions to employers, their workforces and Medicare beneficiaries in local markets across the country. Dan has also held leadership roles in Network and Clinical Services and was a key leader on the Transformation team during the integration with CVS Health – where he worked to utilize CVS Health’s capabilities to increase member connections and deliver less expensive, simple, and seamless health care experiences.
Prior to joining Aetna, he served as President and Chief Operating Officer of EmblemHealth, and previously spent more than a decade at Anthem Inc. in various national executive roles in health care operations, government programs and pharmacy benefit management.
Active in the community, Dan has served on multiple boards including the Alzheimer's Association of New York City, The Battery Park Conservancy, America's Health Insurance Plans, and the New York Health Plan Association.
Dan holds a bachelor’s degree in natural sciences from Xavier University, a bachelor’s degree in pharmacy from the University of Cincinnati and a master’s degree in business administration from Xavier University. He is also a registered pharmacist.
What is Daniel P. Finke's net worth?
The estimated net worth of Daniel P. Finke is at least $182,998.86 as of April 4th, 2022. Finke owns 3,098 shares of CVS Health stock worth more than $182,999 as of December 3rd. This net worth approximation does not reflect any other investments that Finke may own. Learn More about Daniel P. Finke's net worth.
How do I contact Daniel P. Finke?
Has Daniel P. Finke been buying or selling shares of CVS Health?
Daniel P. Finke has not been actively trading shares of CVS Health over the course of the past ninety days. Most recently, Daniel P. Finke sold 55,359 shares of the business's stock in a transaction on Monday, April 4th. The shares were sold at an average price of $100.13, for a transaction totalling $5,543,096.67. Following the completion of the sale, the executive vice president now directly owns 3,098 shares of the company's stock, valued at $310,202.74. Learn More on Daniel P. Finke's trading history.
Who are CVS Health's active insiders?
CVS Health's insider roster includes Lisa Bisaccia (EVP), Eva Boratto (Former CFO), Troyen Brennan (EVP), James Clark (SVP), Alexander Cunningham (Exec. VP & COO of Aetna business ), Daniel Finke (EVP), Joshua Flum (EVP), Shawn Guertin (Exec. VP & CFO ), Alan Lotvin (EVP), Edward Ludwig (Director), Karen Lynch (EVP), Larry Merlo (Director), Thomas Moriarty (EVP), Jonathan Roberts (COO), and Prem Shah (EVP). Learn More on CVS Health's active insiders.
Are insiders buying or selling shares of CVS Health?
In the last twelve months, CVS Health insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $53,880.00. In the last twelve months, insiders at the pharmacy operator sold shares 1 times. They sold a total of 29,473 shares worth more than $2,267,947.35. The most recent insider tranaction occured on May, 2nd when Director Edward J Ludwig bought 1,000 shares worth more than $53,880.00. Insiders at CVS Health own 0.2% of the company.
Learn More about insider trades at CVS Health. Information on this page was last updated on 5/2/2024.